Agios Pharmaceuticals

Agios Pharmaceuticals

Pharmaceutical Manufacturing

Cambridge, MA 75,488 followers

Where science meets heart. Passionately committed to transforming the lives of people with genetically defined diseases.

About us

Agios is a biopharmaceutical company that is fueled by connections. We are passionately committed to applying our leadership in the field of cellular metabolism to create life-changing therapies for people living with rare diseases. The bonds we build with patient communities, healthcare professionals, partners and colleagues help elevate our thinking and propel our science to new heights. These connections, combined with our cellular metabolism expertise, have fueled the development and approval of our first-in-class pyruvate kinase (PK) activator, as well as other investigational therapies. We’re a company that cares about our work, each other, and the people who are counting on us the most. We’re inspired to think big and welcome the different perspectives and backgrounds needed to deliver extraordinary results.

Website
http://www.agios.com
Industry
Pharmaceutical Manufacturing
Company size
201-500 employees
Headquarters
Cambridge, MA
Type
Public Company
Founded
2008
Specialties
Biopharmaceuticals, Rare Genetic Diseases, Cellular Metabolism, and Hemolytic Anemias

Locations

Employees at Agios Pharmaceuticals

Updates

Similar pages

Browse jobs

Stock

AGIO

NASDAQ

20 minutes delay

$34.54

-0.04 (-0.116%)

Open
34.9
Low
33.63
High
35.48

Data from Refinitiv

See more info on Bing

Funding

Agios Pharmaceuticals 7 total rounds

Last Round

Post IPO equity

US$ 256.0M

See more info on crunchbase